Volume rising News dropped Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma’s Strategic Investment to Support the Development of Taysha’s AAV-based Gene Therapy Pr
Trade closed: target reached
Target reached see you soon TSHA probably
After Hours it dropped to 2.59 might get better support for future news
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.